Allergy Diagnostics and Therapeutics Market, By Type (Diagnostics and Therapeutics), By Allergen Type, By Test Type, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5219
|
Published Date
May 2026
|
Pages
353
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Allergy Diagnostics and Therapeutics Market size was valued at US$ 37,105.11 Million in 2025, expanding at a CAGR of 10.6% from 2026 to 2033.
Allergy diagnostics and therapeutics refer to the medical procedures and treatments used to identify allergic triggers and manage the immune system’s response in order to reduce symptoms and prevent severe reactions. Diagnostic approaches include skin prick tests, blood tests, and other laboratory methods that help clinicians determine the specific substances responsible for allergic responses. Therapeutic options include antihistamines, corticosteroids, immunotherapy, biologics, and emergency treatments for severe allergic reactions. These approaches are commonly used in the management of food allergies, asthma, allergic rhinitis, skin allergies, and drug allergies.
This field supports both hospital-based care and home management by helping patients control symptoms and avoid exposure to allergens in daily life. International health organizations such as the World Allergy Organization emphasize that a significant portion of the global population is affected by allergic diseases. Similarly, the Centers for Disease Control and Prevention reports a steady increase in diagnosed allergy cases across various age groups. Public healthcare systems and regulatory authorities in many regions are also promoting early screening, preventive care, and improved access to emergency treatments, contributing to the growing adoption of advanced diagnostic tools and modern therapeutic solutions in global healthcare systems.
Allergy Diagnostics and Therapeutics Market- Market Dynamics
Increasing awareness and early detection of allergic conditions driving market growth
Growing awareness of allergic conditions and the importance of early diagnosis is driving demand for allergy diagnostics and therapeutics. More patients are now seeking medical attention at the initial stage of symptoms rather than delaying treatment, enabling timely intervention and improved disease management outcomes. Healthcare systems in many regions are also promoting routine screening for respiratory and skin-related allergies, making diagnostic testing increasingly common in primary care settings.
For example, the European Centre for Disease Prevention and Control has reported increased recognition and monitoring of respiratory allergy cases. The National Health Service has established allergy clinics and referral pathways to support early diagnosis and treatment. In India, the Ministry of Health and Family Welfare continues to promote awareness programs for asthma and allergy management under national health initiatives. From an industry perspective, Thermo Fisher Scientific provides widely used allergy testing solutions in clinical laboratories for identifying specific IgE responses. These developments are improving access to early detection and are contributing to the growing demand for allergy diagnostics and treatment solutions.
Allergy Diagnostics and Therapeutics Market- Segmentation Analysis:
The Global Allergy Diagnostics and Therapeutics Market is segmented on the basis of Type, Allergen Type, Test Type, End User, and Region.
According to type categories, therapeutics—particularly immunotherapy—plays a significant role due to its long-term approach in managing allergic conditions rather than merely controlling symptoms. Immunotherapy works by gradually modifying the immune response, helping patients reduce sensitivity to allergens over time, which makes it a preferred option for chronic allergy management. Among industry participants, Regeneron Pharmaceuticals has developed biologic therapies targeting immune pathways involved in severe allergic reactions, supporting sustained symptom control. Similarly, Novartis has expanded its immunology-focused portfolio with therapies designed for long-term respiratory and allergy-related conditions, reflecting growing clinical demand.
Under test type classification, in vivo tests—particularly skin prick testing—remain widely used in clinical practice due to their rapid results, cost efficiency, and ability to demonstrate real-time immune responses on the skin. These tests are commonly preferred in hospitals and allergy clinics for initial screening of respiratory, food, and environmental allergies. Their simplicity and immediate response make them especially valuable in routine diagnosis where quick clinical decisions are required. From a technological standpoint, Siemens Healthineers supports diagnostic workflows through integrated laboratory systems that assist in allergy testing and patient screening. Similarly, bioMérieux provides in vitro diagnostic solutions that support allergy testing environments, enabling accurate identification of immune responses in clinical laboratories.
Allergy Diagnostics and Therapeutics Market- Geographical Insights
A closer geographical assessment of the allergy diagnostics and therapeutics market indicates that North America plays a key role in shaping demand and innovation, largely due to advanced healthcare systems and high awareness of allergic conditions. The Centers for Disease Control and Prevention reports that approximately 31.7 million adults in the United States live with seasonal allergies, eczema, or food allergy conditions, highlighting a substantial patient population requiring ongoing diagnosis and care. The U.S. Food and Drug Administration has also approved multiple allergy-related biologic therapies aimed at improving outcomes for patients with severe allergic conditions, supporting continued therapeutic innovation in this field. The National Institute of Allergy and Infectious Diseases continues to fund research focused on immunotherapy and allergen prevention strategies, strengthening scientific advancement in allergy management. On the industry side, Sanofi has expanded the approved use of Dupixent across multiple allergic and inflammatory conditions in the United States, broadening its therapeutic applications across several indications.
Japan Allergy Diagnostics and Therapeutics Market- Country Insights
Japan exhibits a well-organized healthcare system where awareness of allergic conditions is steadily increasing alongside broader public health priorities. The country has a strong culture of preventive care, and patients generally have good access to medical consultation and diagnostic services. Allergy-related conditions such as seasonal reactions, respiratory sensitivities, and food intolerances are managed through structured clinical practices supported by advanced hospital networks and specialized allergy clinics. The Ministry of Health, Labour and Welfare (MHLW) has reported a steady rise in allergic rhinitis cases, particularly among younger populations, which has encouraged wider adoption of diagnostic testing and preventive care approaches.
Furthermore, the National Institute of Health Sciences in Japan conducts ongoing surveillance programs on food and environmental allergens to strengthen early detection and improve safety standards. From an industry perspective, Shionogi & Co., Ltd. is expanding its immunology research focus to support targeted allergy treatment development, including biologics-based therapies. Similarly, Torii Pharmaceutical is actively engaged in allergen immunotherapy solutions, particularly for respiratory allergies that are prevalent in Japan.
Allergy Diagnostics and Therapeutics Market- Competitive Landscape:
The allergy diagnostics and therapeutics sector is evolving as healthcare companies, diagnostic firms, and biotechnology organizations collaborate to improve early detection and treatment of allergic conditions. The industry is supported by ongoing clinical research, advancements in laboratory testing methods, and wider adoption of personalized medicine approaches. Companies such as Thermo Fisher Scientific, Danaher Corporation, Siemens Healthineers, and bioMérieux are contributing through advanced diagnostic platforms and immunoassay technologies. These companies focus on improving test accuracy, accelerating result delivery, and expanding access to allergy screening in hospitals and laboratories, thereby supporting more effective patient management in clinical practice.
Their growth is further shaped by biotechnology and pharmaceutical companies investing in biologics, immunotherapy solutions, and targeted allergy treatments. Companies such as Sanofi, Regeneron Pharmaceuticals, Novartis, and Stallergenes Greer are actively advancing long-term allergy care through expanded drug pipelines and immune-modulating therapies. For instance, Sanofi has extended its biologics research programs to support severe allergy and asthma treatment solutions, while Regeneron continues to develop antibody-based therapies aimed at reducing allergic immune responses.
Recent Developments
- In March 2026, GlaxoSmithKline completed the acquisition of RAPT Therapeutics to strengthen its allergy and immunology treatment pipeline. The deal includes ozureprubart, a long-acting anti-IgE antibody therapy being studied for food allergy protection, potentially enabling broader treatment options with less frequent dosing schedules.
- In October 2025, Thermo Fisher Scientific announced the acquisition of clinical trial technology provider Clario for up to USD 9.4 billion, aimed at enhancing digital clinical research capabilities supporting drug development, including immunology and allergy-related studies.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific
- Danaher Corporation
- Siemens Healthineers
- bioMérieux
- F. Hoffmann-La Roche
- Abbott Laboratories
- Regeneron
- Euroimmun (PerkinElmer)
- AESKU.GROUP
- R-Biopharm AG
- HYCOR Biomedical
- Stallergenes Greer
- Allergy Therapeutics
- ALK-Abelló
- Sanofi
- Novartis
- GSK
- Pfizer
- Merck & Co.
- Astellas Pharma
- Sun Pharmaceutical Industries
- AbbVie
- Others
GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Diagnostics
- Consumables
- Instruments
- Services
- Therapeutics
- Immunotherapy
- Antihistamines
- Decongestants
- Epinephrine
- Corticosteroids
- Mast Cell Stabilizers
- Nasal Anticholinergic
- Leukotriene Inhibitors
- Immunomodulators
- Others
GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY ALLERGEN TYPE- MARKET ANALYSIS, 2020 - 2033
- Food
- Soy
- Peanuts
- Tree Nuts
- Shellfish
- Wheat
- Poultry Products
- Dairy Products
- Other Food Allergens
- Inhaled
- Drug
- Others
GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2020 - 2033
- In Vivo Tests
- Patch Test
- Skin Prick Test
- Intradermal Test
- In Vitro Tests
- ELISA Test
- Specific IgE Blood Test
- Others
GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Specialty Clinics
- Diagnostics Laboratories
- Ambulatory Care Centers
- Research & Development Centers
- Others
GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Allergy Diagnostics And Therapeutics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Allergy Diagnostics And Therapeutics Market Snippet by Type
2.1.2. Allergy Diagnostics And Therapeutics Market Snippet by Allergen Type
2.1.3. Allergy Diagnostics And Therapeutics Market Snippet by Test Type
2.1.4. Allergy Diagnostics And Therapeutics Market Snippet by End User
2.1.5. Allergy Diagnostics And Therapeutics Market Snippet by Country
2.1.6. Allergy Diagnostics And Therapeutics Market Snippet by Region
2.2. Competitive Insights
3. Allergy Diagnostics And Therapeutics Key Market Trends
3.1. Allergy Diagnostics And Therapeutics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Allergy Diagnostics And Therapeutics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Allergy Diagnostics And Therapeutics Market Opportunities
3.4. Allergy Diagnostics And Therapeutics Market Future Trends
4. Allergy Diagnostics And Therapeutics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Allergy Diagnostics And Therapeutics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Allergy Diagnostics And Therapeutics Market Landscape
6.1. Allergy Diagnostics And Therapeutics Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Allergy Diagnostics And Therapeutics Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
7.1.2. Diagnostics
7.1.2.1. Consumables
7.1.2.2. Instruments
7.1.2.3. Services
7.1.3. Therapeutics
7.1.3.1. Immunotherapy
7.1.3.2. Antihistamines
7.1.3.3. Decongestants
7.1.3.4. Epinephrine
7.1.3.5. Corticosteroids
7.1.3.6. Mast Cell Stabilizers
7.1.3.7. Nasal Anticholinergic
7.1.3.8. Leukotriene Inhibitors
7.1.3.9. Immunomodulators
7.1.4. Others
8. Allergy Diagnostics And Therapeutics Market – By Allergen Type
8.1. Overview
8.1.1. Segment Share Analysis, By Allergen Type, 2025 & 2033 (%)
8.1.2. Food
8.1.2.1. Soy
8.1.2.2. Peanuts
8.1.2.3. Tree Nuts
8.1.2.4. Shellfish
8.1.2.5. Wheat
8.1.2.6. Poultry Products
8.1.2.7. Dairy Products
8.1.2.8. Other Food Allergens
8.1.3. Inhaled
8.1.4. Drug
8.1.5. Others
9. Allergy Diagnostics And Therapeutics Market – By Test Type
9.1. Overview
9.1.1. Segment Share Analysis, By Test Type, 2025 & 2033 (%)
9.1.2. In Vivo Tests
9.1.2.1. Patch Test
9.1.2.2. Skin Prick Test
9.1.2.3. Intradermal Test
9.1.3. In Vitro Tests
9.1.3.1. ELISA Test
9.1.3.2. Specific IgE Blood Test
9.1.4. Others
10. Allergy Diagnostics And Therapeutics Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
10.1.2. Hospitals
10.1.3. Specialty Clinics
10.1.4. Diagnostics Laboratories
10.1.5. Ambulatory Care Centers
10.1.6. Research & Development Centers
10.1.7. Others
11. Allergy Diagnostics And Therapeutics Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Allergy Diagnostics And Therapeutics Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Allergy Diagnostics And Therapeutics Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Allergy Diagnostics And Therapeutics Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Allergy Diagnostics And Therapeutics Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Allergy Diagnostics And Therapeutics Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Allergen Type, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Allergy Diagnostics And Therapeutics Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Thermo Fisher Scientific
12.2.2. Danaher Corporation
12.2.3. Siemens Healthineers
12.2.4. bioMérieux
12.2.5. F. Hoffmann-La Roche
12.2.6. Abbott Laboratories
12.2.7. Regeneron
12.2.8. Euroimmun (PerkinElmer)
12.2.9. AESKU.GROUP
12.2.10. R-Biopharm AG
12.2.11. HYCOR Biomedical
12.2.12. Stallergenes Greer
12.2.13. Allergy Therapeutics
12.2.14. ALK-Abelló
12.2.15. Sanofi
12.2.16. Novartis
12.2.17. GSK
12.2.18. Pfizer
12.2.19. Merck & Co.
12.2.20. Astellas Pharma
12.2.21. Sun Pharmaceutical Industries
12.2.22. AbbVie
12.2.23. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific
- Danaher Corporation
- Siemens Healthineers
- bioMérieux
- F. Hoffmann-La Roche
- Abbott Laboratories
- Regeneron
- Euroimmun (PerkinElmer)
- AESKU.GROUP
- R-Biopharm AG
- HYCOR Biomedical
- Stallergenes Greer
- Allergy Therapeutics
- ALK-Abelló
- Sanofi
- Novartis
- GSK
- Pfizer
- Merck & Co.
- Astellas Pharma
- Sun Pharmaceutical Industries
- AbbVie
- Others
GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Diagnostics
- Consumables
- Instruments
- Services
- Therapeutics
- Immunotherapy
- Antihistamines
- Decongestants
- Epinephrine
- Corticosteroids
- Mast Cell Stabilizers
- Nasal Anticholinergic
- Leukotriene Inhibitors
- Immunomodulators
- Others
GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY ALLERGEN TYPE- MARKET ANALYSIS, 2020 - 2033
- Food
- Soy
- Peanuts
- Tree Nuts
- Shellfish
- Wheat
- Poultry Products
- Dairy Products
- Other Food Allergens
- Inhaled
- Drug
- Others
GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2020 - 2033
- In Vivo Tests
- Patch Test
- Skin Prick Test
- Intradermal Test
- In Vitro Tests
- ELISA Test
- Specific IgE Blood Test
- Others
GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Specialty Clinics
- Diagnostics Laboratories
- Ambulatory Care Centers
- Research & Development Centers
- Others
GLOBAL ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
